BDBM696821 US20240308985, Compound 414::US20240308985, Compound 487

SMILES Oc1ccc(F)c(c1)C(=O)N1CC2(CC(C2)n2nc(cc2-c2ccccc2C(F)(F)F)C(F)(F)F)C1

InChI Key InChIKey=GZAIUBDLKQVMOO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 696821   

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696821(US20240308985, Compound 414 | US20240308985, Compo...)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696821(US20240308985, Compound 414 | US20240308985, Compo...)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent